BlackRock Fund Advisors’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $9K | Hold |
632
| – | – | ﹤0.01% | 3979 |
|
|
2016
Q3 | $8K | Buy |
632
+27
| +4% | +$342 | ﹤0.01% | 3997 |
|
|
2016
Q2 | $6K | Sell |
605
-67,014
| -99% | -$665K | ﹤0.01% | 4064 |
|
|
2016
Q1 | $568K | Sell |
67,619
-2,265
| -3% | -$19K | ﹤0.01% | 3225 |
|
|
2015
Q4 | $861K | Sell |
69,884
-53,293
| -43% | -$657K | ﹤0.01% | 3245 |
|
|
2015
Q3 | $7.5M | Buy |
123,177
+5,472
| +5% | +$333K | ﹤0.01% | 2554 |
|
|
2015
Q2 | $9.19M | Buy |
117,705
+24,492
| +26% | +$1.91M | ﹤0.01% | 2558 |
|
|
2015
Q1 | $6.33M | Buy |
93,213
+4,381
| +5% | +$297K | ﹤0.01% | 2708 |
|
|
2014
Q4 | $8.24M | Buy |
88,832
+8,299
| +10% | +$770K | ﹤0.01% | 2575 |
|
|
2014
Q3 | $8.48M | Buy |
80,533
+8,336
| +12% | +$878K | ﹤0.01% | 2451 |
|
|
2014
Q2 | $10.3M | Buy |
72,197
+2,170
| +3% | +$311K | ﹤0.01% | 2393 |
|
|
2014
Q1 | $10.6M | Buy |
70,027
+4,509
| +7% | +$680K | ﹤0.01% | 2373 |
|
|
2013
Q4 | $12M | Buy |
65,518
+11,064
| +20% | +$2.03M | ﹤0.01% | 2278 |
|
|
2013
Q3 | $12M | Buy |
54,454
+6,750
| +14% | +$1.49M | ﹤0.01% | 2244 |
|
|
2013
Q2 | $8.33M | Buy |
+47,704
| New | +$8.33M | ﹤0.01% | 2367 |
|